Phage Therapy And Synthetic Microbiome Engineering Market
Phage Therapy & Synthetic Microbiome Engineering Market Forecasts to 2034 - Global Analysis By Product (Therapeutic Bacteriophage Preparations, Personalized Phage Cocktails, Engineered Synthetic Phages, Microbiome Therapeutic Consortia, Other Products), By Target Pathogen, By Technology, By Application, By End User and By Geography
According to Stratistics MRC, the Global Phage Therapy & Synthetic Microbiome Engineering Market is accounted for $1.3 billion in 2026 and is expected to reach $1.8 billion by 2034 growing at a CAGR of 4.1% during the forecast period. Phage Therapy & Synthetic Microbiome Engineering involves the use of bacteriophages viruses that specifically target bacteria—and engineered microbial communities to treat infections and restore healthy microbiomes. Phage therapy selectively eliminates harmful bacteria while preserving beneficial microbes, making it a promising alternative to antibiotics. Synthetic microbiome engineering uses designed microbial consortia to modulate gut or environmental microbiomes for therapeutic purposes. These approaches address antibiotic resistance, improve disease treatment, and support personalized medicine by leveraging precision microbiology and advances in biotechnology.
Market Dynamics:
Driver:
Rising antimicrobial resistance globally
Many bacterial infections are becoming increasingly resistant to conventional antibiotics. This has created an urgent need for alternative therapeutic approaches. Phage therapy uses bacteriophages that specifically target and destroy harmful bacteria. These therapies provide a promising solution for infections that no longer respond to antibiotics. As antibiotic resistance continues to rise worldwide, interest in phage-based treatments is growing rapidly.
Restraint:
Complex regulatory approval processes
Regulatory frameworks for phage therapies are still evolving in many countries. These treatments often require customized formulations for individual patients. This makes standardization and large-scale clinical validation more challenging. Regulatory authorities require extensive safety and efficacy data before approval. These factors can delay commercialization and limit market growth.
Opportunity:
Personalized phage therapy developments
Personalized treatments use specific bacteriophages tailored to a patient’s bacterial infection. Advances in genomics and microbiome research are supporting the development of such targeted therapies. These solutions can provide highly precise treatment with minimal impact on beneficial bacteria. Research institutions and biotech companies are actively investing in personalized phage therapy platforms. As personalized medicine gains popularity, demand for tailored phage therapies is expected to increase.
Threat:
Bacterial resistance to phage therapies
Although bacteriophages can adapt and evolve, bacteria may still develop defense mechanisms against them. Continuous monitoring and development of new phage strains are required to maintain effectiveness. This process can increase research and development costs. Additionally, large-scale production and stability of phage preparations can be technically complex. These challenges may affect long-term adoption of phage therapy solutions.
Covid-19 Impact:
The COVID-19 pandemic influenced research activities in the phage therapy and microbiome engineering market. During the early stages of the pandemic, many research programs were temporarily delayed. Healthcare systems prioritized COVID-19 treatment and vaccine development. However, the pandemic highlighted the importance of advanced infectious disease therapies. Researchers increased focus on innovative solutions for antimicrobial resistance. As a result, interest in phage therapy research and investment has continued to grow.
The antibiotic-resistant bacteria segment is expected to be the largest during the forecast period
The antibiotic-resistant bacteria segment is expected to account for the largest market share during the forecast period because phage therapy is particularly effective against bacteria that do not respond to antibiotics. Many healthcare systems are facing increasing cases of multidrug-resistant infections. Phage therapies offer a targeted and efficient treatment option for such infections. Hospitals and research institutions are actively studying phage applications for resistant pathogens. These factors support the dominance of the antibiotic-resistant bacteria segment.
The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceutical companies segment is predicted to witness the highest growth rate due to increased investment in phage therapy research and microbiome-based therapeutics. These companies are conducting clinical trials to develop new phage-based drugs. Partnerships between biotech firms and pharmaceutical companies are also increasing. Growing interest in alternative antimicrobial therapies further supports this trend. As drug development activities expand, pharmaceutical companies will play a major role in market growth.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share owing to strong biotechnology research infrastructure and advanced healthcare systems. Many leading biotech companies and research institutions are developing phage therapies. Government funding for antimicrobial resistance research also supports innovation. Additionally, the region has a strong presence of pharmaceutical companies working on microbiome-based therapeutics. These factors contribute to North America’s leading position in the market.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rising healthcare investments and increasing research activities are driving market growth in this region. Countries such as China, Japan, and South Korea are expanding biotechnology research capabilities. Growing awareness of antimicrobial resistance is also encouraging the adoption of new therapies. Government initiatives supporting advanced healthcare technologies further boost the market.
Key players in the market
Some of the key players in Phage Therapy & Synthetic Microbiome Engineering Market include Adaptive Phage Therapeutics, Pherecydes Pharma, Armata Pharmaceuticals, Inc., Locus Biosciences, Inc., Synthego Corporation, Synlogic, Inc., Seres Therapeutics, Inc., Second Genome, Inc., Enterome SA, Microbiotica Ltd., Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Johnson & Johnson and Eligo Bioscience.
Key Developments:
In May 2025, Synthego expanded its CRISPR portfolio with the launch of GMP SpCas9, a nuclease manufactured under current Good Manufacturing Practice (cGMP) standards . This product is designed to be bundled with their GMP guide RNAs to streamline the development of CRISPR-based therapeutics for clinical studies.
In November 2023, Pherecydes Pharma company was acquired by the ERBC Group, a French preclinical Contract Research Organization (CRO). This strategic move transitioned Pherecydes from a standalone biotech into the "Phage Unit" of ERBC, aiming to leverage its expertise to offer phagogram services to hospital clients seeking personalized anti-bacterial treatments.
Products Covered:
• Therapeutic Bacteriophage Preparations
• Personalized Phage Cocktails
• Engineered Synthetic Phages
• Microbiome Therapeutic Consortia
• Other Products
Target Pathogens Covered:
• Antibiotic-Resistant Bacteria
• Staphylococcus Infections
• Pseudomonas Infections
• E. coli Infections
• Other Target Pathogens
Technologies Covered:
• CRISPR-Based Phage Engineering
• Synthetic Biology Platforms
• Directed Evolution Techniques
• AI-Based Phage Design
• Other Technologies
Applications Covered:
• Infectious Disease Treatment
• Gastrointestinal Disorders
• Skin & Wound Care
• Respiratory Infections
• Other Applications
End Users Covered:
• Hospitals
• Biotechnology Companies
• Pharmaceutical Companies
• Academic & Research Institutes
• Veterinary Clinics
• Agricultural Enterprises
• Other End Users
Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
§ Saudi Arabia
§ United Arab Emirates
§ Qatar
§ Israel
§ Rest of Middle East
o Africa
§ South Africa
§ Egypt
§ Morocco
§ Rest of Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 Research Framework
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 Market Dynamics and Trend Analysis
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 Competitive and Strategic Assessment
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Product
5.1 Therapeutic Bacteriophage Preparations
5.2 Personalized Phage Cocktails
5.3 Engineered Synthetic Phages
5.4 Microbiome Therapeutic Consortia
5.5 Other Products
6 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Target Pathogen
6.1 Antibiotic-Resistant Bacteria
6.2 Staphylococcus Infections
6.3 Pseudomonas Infections
6.4 E. coli Infections
6.5 Other Target Pathogens
7 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Technology
7.1 CRISPR-Based Phage Engineering
7.2 Synthetic Biology Platforms
7.3 Directed Evolution Techniques
7.4 AI-Based Phage Design
7.5 Other Technologies
8 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Application
8.1 Infectious Disease Treatment
8.2 Gastrointestinal Disorders
8.3 Skin & Wound Care
8.4 Respiratory Infections
8.5 Other Applications
9 Global Phage Therapy & Synthetic Microbiome Engineering Market, By End User
9.1 Hospitals
9.2 Biotechnology Companies
9.3 Pharmaceutical Companies
9.4 Academic & Research Institutes
9.5 Veterinary Clinics
9.6 Agricultural Enterprises
9.7 Other End Users
10 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Geography
10.1 North America
10.1.1 United States
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 United Kingdom
10.2.2 Germany
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Netherlands
10.2.7 Belgium
10.2.8 Sweden
10.2.9 Switzerland
10.2.10 Poland
10.2.11 Rest of Europe
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Australia
10.3.6 Indonesia
10.3.7 Thailand
10.3.8 Malaysia
10.3.9 Singapore
10.3.10 Vietnam
10.3.11 Rest of Asia Pacific
10.4 South America
10.4.1 Brazil
10.4.2 Argentina
10.4.3 Colombia
10.4.4 Chile
10.4.5 Peru
10.4.6 Rest of South America
10.5 Rest of the World (RoW)
10.5.1 Middle East
10.5.1.1 Saudi Arabia
10.5.1.2 United Arab Emirates
10.5.1.3 Qatar
10.5.1.4 Israel
10.5.1.5 Rest of Middle East
10.5.2 Africa
10.5.2.1 South Africa
10.5.2.2 Egypt
10.5.2.3 Morocco
10.5.2.4 Rest of Africa
11 Strategic Market Intelligence
11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment
12 Industry Developments and Strategic Initiatives
12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives
13 Company Profiles
13.1 Adaptive Phage Therapeutics
13.2 Pherecydes Pharma
13.3 Armata Pharmaceuticals, Inc.
13.4 Locus Biosciences, Inc.
13.5 Synthego Corporation
13.6 Synlogic, Inc.
13.7 Seres Therapeutics, Inc.
13.8 Second Genome, Inc.
13.9 Enterome SA
13.10 Microbiotica Ltd.
13.11 Pfizer Inc.
13.12 F. Hoffmann-La Roche Ltd.
13.13 Novartis AG
13.14 Johnson & Johnson
13.15 Eligo Bioscience
List of Tables
1 Global Phage Therapy & Synthetic Microbiome Engineering Market Outlook, By Region (2023-2034) ($MN)
2 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Product (2023–2034) ($MN)
3 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Therapeutic Bacteriophage Preparations (2023–2034) ($MN)
4 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Personalized Phage Cocktails (2023–2034) ($MN)
5 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Engineered Synthetic Phages (2023–2034) ($MN)
6 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Microbiome Therapeutic Consortia (2023–2034) ($MN)
7 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Other Products (2023–2034) ($MN)
8 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Target Pathogen (2023–2034) ($MN)
9 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Antibiotic-Resistant Bacteria (2023–2034) ($MN)
10 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Staphylococcus Infections (2023–2034) ($MN)
11 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Pseudomonas Infections (2023–2034) ($MN)
12 Global Phage Therapy & Synthetic Microbiome Engineering Market, By E. coli Infections (2023–2034) ($MN)
13 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Other Target Pathogens (2023–2034) ($MN)
14 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Technology (2023–2034) ($MN)
15 Global Phage Therapy & Synthetic Microbiome Engineering Market, By CRISPR-Based Phage Engineering (2023–2034) ($MN)
16 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Synthetic Biology Platforms (2023–2034) ($MN)
17 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Directed Evolution Techniques (2023–2034) ($MN)
18 Global Phage Therapy & Synthetic Microbiome Engineering Market, By AI-Based Phage Design (2023–2034) ($MN)
19 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Other Technologies (2023–2034) ($MN)
20 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Application (2023–2034) ($MN)
21 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Infectious Disease Treatment (2023–2034) ($MN)
22 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Gastrointestinal Disorders (2023–2034) ($MN)
23 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Skin & Wound Care (2023–2034) ($MN)
24 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Respiratory Infections (2023–2034) ($MN)
25 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Other Applications (2023–2034) ($MN)
26 Global Phage Therapy & Synthetic Microbiome Engineering Market, By End User (2023–2034) ($MN)
27 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Hospitals (2023–2034) ($MN)
28 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Biotechnology Companies (2023–2034) ($MN)
29 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Pharmaceutical Companies (2023–2034) ($MN)
30 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Academic & Research Institutes (2023–2034) ($MN)
31 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Veterinary Clinics (2023–2034) ($MN)
32 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Agricultural Enterprises (2023–2034) ($MN)
33 Global Phage Therapy & Synthetic Microbiome Engineering Market, By Other End Users (2023–2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
